A detailed history of Narwhal Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Narwhal Capital Management holds 15,859 shares of ZTS stock, worth $1.88 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
15,859
Previous 4,215 276.25%
Holding current value
$1.88 Million
Previous $657,000 253.12%
% of portfolio
0.18%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$141.13 - $159.19 $1.64 Million - $1.85 Million
11,644 Added 276.25%
15,859 $2.32 Million
Q2 2025

Jul 23, 2025

BUY
$144.41 - $170.3 $608,688 - $717,814
4,215 New
4,215 $657,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Narwhal Capital Management Portfolio

Follow Narwhal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.